Tuesday, April 2nd, at 9:30am ET, the Senate Special Committee on Aging will hold a hearing entitled “Alzheimer’s: New Directions in Biomedical Research and Caregiving.” Dr. Richard Hodes, the NIA Director, will be one of four witnesses at this hearing. Check the committee website for the videocast.
On March 26 at 2:00pm ET, Dr. Robin Barr, the NIA Director of the Division of Extramural Activities, will host a webinar on a variety of topics, including: NIA funding priorities, increased funding for Alzheimer’s disease (AD), small business opportunities, and tips on writing successful applications. After a brief presentation, Dr. Barr will open the floor to questions from the research community. NIA invites all interested members of the research community to register for the webinar and submit your questions in advance of the event. For more information, please see Dr. Barr’s blog on the topic: March 26 Webinar: (Almost) everything you wanted to know about NIA funding but were afraid to ask.
Friends of NIA hosted an educational briefing on May 9, 2018 on Translating Scientific Discovery into Better Care: Groundbreaking Research at the National Institute on Aging. Featured speakers included Richard Hodes, MD, Director of the NIA and Marie A. Bernard, MD, Deputy Director of the NIA. Special guests included The Honorable Ed Markey (MA), Senate Co-Chair, The Bipartisan Congressional Task Force on Alzheimer’s Disease and The Honorable Earl Blumenauer (OR), Co-Chair, Congressional Neuroscience Caucus.
Please join the Friends of the National Institute on Aging to hear about the groundbreaking aging research that is being supported by the National Institute on Aging (NIA). The NIA, one of 27 Institutes comprising the National Institutes of Health (NIH), leads the national scientific effort to promote the health and well-being of older adults. It will be held on Thursday, June 30, 2016, 2:00-3:00 p.m. at the Capitol Visitorʼs Center, SVC 201, U.S. Capitol Building, Washington, D.C. To RSVP for the event, please go here. To download details, please click here.
Below is an agenda of the event:
Welcome & Introductions
Kathryn Jedrziewski, Ph.D.
Chair, Friends of the NIA
Deputy Director, Pennʼs Institute on Aging
Advances at the NIA: From Bench to Bedside to Real-World Practice
Richard Hodes, M.D.
Director, National Institute on Aging
Marie A. Bernard, M.D.
Deputy Director, National Institute on Aging
Precision Medicine Approaches for Treatment of Alzheimerʼs & Parkinsonʼs
Corey McMillan, Ph.D.
Research Assistant Professor of Neurology, University of Pennsylvania
Training the Next Generation
Peter M. Abadir, M.D.
Assistant Professor of Medicine,
Johns Hopkins University School of Medicine, Division of Geriatric Medicine and Gerontology
The Friends of the NIA (FoNIA) held a Capitol Hill briefing on June 22 on “Turning Discovery into Health: Learn about the Latest at the National Institute on Aging.”
The briefing started out with updates from NIA Director Dr. Richard Hodes and Deputy Director Dr. Marie A. Bernard on the latest groundbreaking research activities and outreach efforts within the organization. Dr. Neil Buckholtz, director of the NIA’s Division of Neuroscience, also shared the results from the 2015 Alzheimer’s Disease Research Summit.
Dr. Kathryn Jedrziewski, FoNIA co-chair and deputy director, Institute on Aging, University of Pennsylvania, gave insights on the role the NIA plays in advancing research at her institute.
Susan Peschin, MHS, FoNIA chair and president & CEO of the Alliance, concluded the briefing with a recap on recent FoNIA activities as well as an update on the policy front. She shared some encouraging news about NIA FY 2016 funding (and National Institutes of Health funding in general).
“This past week, we had an exciting surprise from the House Appropriations Labor, HHS Subcommittee,” said Peschin. “Their bill provides $31.2 billion for the NIH, $1.1 billion above the fiscal year 2015 enacted level. The bill also includes a more than 25 percent increase for the National Institute on Aging to $1.5 billion and a call for $300 million of that increase to be used for Alzheimer’s disease research.”
This research funding is a wise investment, noted Peschin, but she also cautioned more support will be needed to address the coming impact of an aging population and the expected rise in chronic diseases it will bring.
“We understand that things are tight, but we also know that this funding is the minimum essential to sustain research needed to make progress in attacking the chronic diseases that are driving significant increases in our national health care costs,” she said.